Williams GV - Search Results

1

Neuroplasticity as a target for the pharmacotherapy of anxiety disorders, mood disorders, and schizophrenia.

Krystal JH, Tolin DF, Sanacora G, Castner SA, Williams GV, Aikins DE, Hoffman RE, D'Souza DC. Krystal JH, et al. Among authors: williams gv. Drug Discov Today. 2009 Jul;14(13-14):690-7. doi: 10.1016/j.drudis.2009.05.002. Epub 2009 May 19. Drug Discov Today. 2009. PMID: 19460458 Free PMC article. Review.

2

Reversal of antipsychotic-induced working memory deficits by short-term dopamine D1 receptor stimulation.

Castner SA, Williams GV, Goldman-Rakic PS. Castner SA, et al. Among authors: williams gv. Science. 2000 Mar 17;287(5460):2020-2. doi: 10.1126/science.287.5460.2020. Science. 2000. PMID: 10720329

3

Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction.

Goldman-Rakic PS, Castner SA, Svensson TH, Siever LJ, Williams GV. Goldman-Rakic PS, et al. Among authors: williams gv. Psychopharmacology (Berl). 2004 Jun;174(1):3-16. doi: 10.1007/s00213-004-1793-y. Epub 2004 Apr 30. Psychopharmacology (Berl). 2004. PMID: 15118803 Review.

4

Animal models of working memory: insights for targeting cognitive dysfunction in schizophrenia.

Castner SA, Goldman-Rakic PS, Williams GV. Castner SA, et al. Among authors: williams gv. Psychopharmacology (Berl). 2004 Jun;174(1):111-25. doi: 10.1007/s00213-003-1710-9. Epub 2004 Jan 20. Psychopharmacology (Berl). 2004. PMID: 15205882 Review.

5

Under the curve: critical issues for elucidating D1 receptor function in working memory.

Williams GV, Castner SA. Williams GV, et al. Neuroscience. 2006 Apr 28;139(1):263-76. doi: 10.1016/j.neuroscience.2005.09.028. Epub 2005 Nov 28. Neuroscience. 2006. PMID: 16310964 Review.

6

Tuning the engine of cognition: a focus on NMDA/D1 receptor interactions in prefrontal cortex.

Castner SA, Williams GV. Castner SA, et al. Among authors: williams gv. Brain Cogn. 2007 Mar;63(2):94-122. doi: 10.1016/j.bandc.2006.11.002. Epub 2007 Jan 3. Brain Cogn. 2007. PMID: 17204357 Review.

7

Antipsychotics and working memory in schizophrenia.

Aleman A, F de Haan EH, Castner SA, Williams GV, Goldman-Rakic PS. Aleman A, et al. Among authors: williams gv. Science. 2000 Jul 7;289(5476):56b-8b. doi: 10.1126/science.289.5476.56b. Science. 2000. PMID: 17832962 No abstract available.

8

From vice to virtue: insights from sensitization in the nonhuman primate.

Castner SA, Williams GV. Castner SA, et al. Among authors: williams gv. Prog Neuropsychopharmacol Biol Psychiatry. 2007 Nov 15;31(8):1572-92. doi: 10.1016/j.pnpbp.2007.08.026. Epub 2007 Aug 28. Prog Neuropsychopharmacol Biol Psychiatry. 2007. PMID: 17904719 Review.

9

Dissecting the biology of prefrontal cortical dysfunction in schizophrenia: deficiency in mnemonic processing.

Williams GV, Castner SA. Williams GV, et al. Biol Psychiatry. 2008 Dec 15;64(12):1024-5. doi: 10.1016/j.biopsych.2008.10.016. Biol Psychiatry. 2008. PMID: 19038603 No abstract available.

10

Glycine transporter inhibition reverses ketamine-induced working memory deficits.

Roberts BM, Shaffer CL, Seymour PA, Schmidt CJ, Williams GV, Castner SA. Roberts BM, et al. Among authors: williams gv. Neuroreport. 2010 Mar 31;21(5):390-4. doi: 10.1097/WNR.0b013e3283381a4e. Neuroreport. 2010. PMID: 20186106

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

99 results

Search Page

Filters